Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 309

1.

International consensus on quality standards for brain health-focused care in multiple sclerosis.

Hobart J, Bowen A, Pepper G, Crofts H, Eberhard L, Berger T, Boyko A, Boz C, Butzkueven H, Celius EG, Drulovic J, Flores J, Horáková D, Lebrun-Frénay C, Marrie RA, Overell J, Piehl F, Rasmussen PV, Sá MJ, Sîrbu CA, Skromne E, Torkildsen Ø, van Pesch V, Vollmer T, Zakaria M, Ziemssen T, Giovannoni G.

Mult Scler. 2018 Nov 1:1352458518809326. doi: 10.1177/1352458518809326. [Epub ahead of print]

PMID:
30381987
2.

Impact of Glatiramer Acetate on B Cell-Mediated Pathogenesis of Multiple Sclerosis.

Kuerten S, Jackson LJ, Kaye J, Vollmer TL.

CNS Drugs. 2018 Nov;32(11):1039-1051. doi: 10.1007/s40263-018-0567-8. Review.

PMID:
30315499
3.

Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centers.

Vollmer B, Ontaneda D, Bandyopadhyay A, Cohn S, Nair K, Sillau S, Bermel RA, Corboy JR, Fox RJ, Vollmer T, Cohen JA, Alvarez E, Hersh CM.

Neurol Clin Pract. 2018 Aug;8(4):292-301. doi: 10.1212/CPJ.0000000000000487.

4.

The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis.

Vollmer B, Honce JM, Sillau S, Corboy JR, Vollmer T, Nair K, Alvarez E.

J Neurol Sci. 2018 Jul 15;390:89-93. doi: 10.1016/j.jns.2018.04.021. Epub 2018 Apr 13.

PMID:
29801915
5.

Streptococcus gallolyticus subsp. gallolyticus pathogenesis: current state of play.

Grimm I, Vollmer T.

Future Microbiol. 2018 Jun 1;13:731-735. doi: 10.2217/fmb-2018-0053. Epub 2018 May 25. No abstract available.

PMID:
29799280
6.

Retrospective analysis of changes in response topographies of escape-maintained aggressive behavior during functional analyses.

Hernández V, Fernand JK, Vollmer TR, Slocum SK.

J Appl Behav Anal. 2018 Jul;51(3):521-527. doi: 10.1002/jaba.464. Epub 2018 May 13.

PMID:
29756205
7.

Late sampling for automated culture to extend the platelet shelf life to 5 days in Germany.

Vollmer T, Dabisch-Ruthe M, Weinstock M, Knabbe C, Dreier J.

Transfusion. 2018 Jul;58(7):1654-1664. doi: 10.1111/trf.14617. Epub 2018 Apr 15.

PMID:
29656457
8.

An object-oriented computational model to study cardiopulmonary hemodynamic interactions in humans.

Ngo C, Dahlmanns S, Vollmer T, Misgeld B, Leonhardt S.

Comput Methods Programs Biomed. 2018 Jun;159:167-183. doi: 10.1016/j.cmpb.2018.03.008. Epub 2018 Mar 9.

PMID:
29650311
9.

Effects of the Good Behavior Game on student and teacher behavior in an alternative school.

Rubow CC, Vollmer TR, Joslyn PR.

J Appl Behav Anal. 2018 Apr;51(2):382-392. doi: 10.1002/jaba.455. Epub 2018 Apr 2.

PMID:
29608208
10.

Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose.

Dreier J, Knabbe C, Vollmer T.

Front Med (Lausanne). 2018 Feb 1;5:5. doi: 10.3389/fmed.2018.00005. eCollection 2018.

11.

Efficacy of Balance and Eye-Movement Exercises for Persons With Multiple Sclerosis (BEEMS).

Hebert JR, Corboy JR, Vollmer T, Forster JE, Schenkman M.

Neurology. 2018 Feb 27;90(9):e797-e807. doi: 10.1212/WNL.0000000000005013. Epub 2018 Jan 31.

PMID:
29386274
12.

Biofilm formation and transcriptome analysis of Streptococcus gallolyticus subsp. gallolyticus in response to lysozyme.

Grimm I, Dumke J, Dreier J, Knabbe C, Vollmer T.

PLoS One. 2018 Jan 26;13(1):e0191705. doi: 10.1371/journal.pone.0191705. eCollection 2018.

13.

A multicomponent approach to thinning reinforcer delivery during noncontingent reinforcement schedules.

Slocum SK, Grauerholz-Fisher E, Peters KP, Vollmer TR.

J Appl Behav Anal. 2018 Jan;51(1):61-69. doi: 10.1002/jaba.427. Epub 2017 Dec 11.

PMID:
29226346
14.

Strain-dependent interactions of Streptococcus gallolyticus subsp. gallolyticus with human blood cells.

Grimm I, Weinstock M, Birschmann I, Dreier J, Knabbe C, Vollmer T.

BMC Microbiol. 2017 Oct 27;17(1):210. doi: 10.1186/s12866-017-1116-1.

15.

The complex relationship between oligoclonal bands, lymphocytes in the cerebrospinal fluid, and immunoglobulin G antibodies in multiple sclerosis: Indication of serum contribution.

Beseler C, Vollmer T, Graner M, Yu X.

PLoS One. 2017 Oct 23;12(10):e0186842. doi: 10.1371/journal.pone.0186842. eCollection 2017.

16.

Assessing regional lung mechanics by combining electrical impedance tomography and forced oscillation technique.

Ngo C, Spagnesi S, Munoz C, Lehmann S, Vollmer T, Misgeld B, Leonhardt S.

Biomed Tech (Berl). 2017 Aug 29. pii: /j/bmte.ahead-of-print/bmt-2016-0196/bmt-2016-0196.xml. doi: 10.1515/bmt-2016-0196. [Epub ahead of print]

PMID:
28850542
17.

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience.

Vollmer B, Nair KV, Sillau SH, Corboy J, Vollmer T, Alvarez E.

Mult Scler J Exp Transl Clin. 2017 Aug 17;3(3):2055217317725102. doi: 10.1177/2055217317725102. eCollection 2017 Jul-Sep.

18.

Transcriptome analysis of Streptococcus gallolyticus subsp. gallolyticus in interaction with THP-1 macrophage-like cells.

Grimm I, Garben N, Dreier J, Knabbe C, Vollmer T.

PLoS One. 2017 Jul 3;12(7):e0180044. doi: 10.1371/journal.pone.0180044. eCollection 2017.

19.

Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis.

Foley JF, Nair KV, Vollmer T, Stephenson JJ, Niecko T, Agarwal SS, Watson C.

Patient Prefer Adherence. 2017 Jun 16;11:1035-1048. doi: 10.2147/PPA.S134865. eCollection 2017.

20.

Analysis of the psychometric properties of the Multiple Sclerosis Impact Scale-29 (MSIS-29) in relapsing-remitting multiple sclerosis using classical and modern test theory.

Bacci ED, Wyrwich KW, Phillips GA, Vollmer T, Guo S.

Mult Scler J Exp Transl Clin. 2016 Oct 9;2:2055217316673235. doi: 10.1177/2055217316673235. eCollection 2016 Jan-Dec.

21.

Effects of serial and concurrent training on receptive identification tasks: A Systematic replication.

Wunderlich KL, Vollmer TR.

J Appl Behav Anal. 2017 Jul;50(3):641-652. doi: 10.1002/jaba.401. Epub 2017 Jun 8.

PMID:
28594429
22.

Case-control study: Determination of potential risk factors for the colonization of healthy volunteers with Streptococcus gallolyticus subsp. gallolyticus.

Dumke J, Vollmer T, Akkermann O, Knabbe C, Dreier J.

PLoS One. 2017 May 1;12(5):e0176515. doi: 10.1371/journal.pone.0176515. eCollection 2017.

23.

Complete Genome Sequence of the Streptococcus gallolyticus subsp. gallolyticus Strain DSM 16831.

Grimm I, Dumke J, Vollmer T, Hinse D, Rückert C, Kalinowski J, Knabbe C, Dreier J.

Genome Announc. 2017 Apr 20;5(16). pii: e00108-17. doi: 10.1128/genomeA.00108-17.

24.

An object-oriented model of the cardiopulmonary system with emphasis on the gravity effect.

Chuong Ngo, Herranz SB, Misgeld B, Vollmer T, Leonhardt S.

Conf Proc IEEE Eng Med Biol Soc. 2016 Aug;2016:2737-2740. doi: 10.1109/EMBC.2016.7591296.

PMID:
28268885
25.

Laquinimod Safety Profile: Pooled Analyses from the ALLEGRO and BRAVO Trials.

Sørensen PS, Comi G, Vollmer TL, Montalban X, Kappos L, Dadon Y, Gorfine T, Margalit M, Sasson N, Rubinchick S, Knappertz V.

Int J MS Care. 2017 Jan-Feb;19(1):16-24. doi: 10.7224/1537-2073.2015-024.

26.

To PLEX or not to PLEX in natalizumab-associated PML.

Tyler KL, Vollmer TL.

Neurology. 2017 Mar 21;88(12):1108-1109. doi: 10.1212/WNL.0000000000003747. Epub 2017 Feb 22. No abstract available.

PMID:
28228561
27.

Effects of the nasal passage on forced oscillation lung function measurements.

Ngo C, Krüger K, Vollmer T, Winter S, Penzlin B, Lehmann S, Leonhardt S, Misgeld B.

Biomed Tech (Berl). 2017 Nov 27;62(6):635-642. doi: 10.1515/bmt-2016-0158.

PMID:
28222012
28.

Assessment and treatment of automatically reinforced self-induced emesis.

Wunderlich KL, Vollmer TR, Zabala KA.

J Appl Behav Anal. 2017 Apr;50(2):418-423. doi: 10.1002/jaba.371. Epub 2017 Feb 8.

PMID:
28177122
29.

Impact of daclizumab versus interferon beta-1a on patient-reported outcomes in relapsing-remitting multiple sclerosis.

Liu Y, Vollmer T, Havrdova E, Riester K, Lee A, Phillips G, Wang P, Sabatella G.

Mult Scler Relat Disord. 2017 Jan;11:18-24. doi: 10.1016/j.msard.2016.11.005. Epub 2016 Nov 13.

30.

Linearity of electrical impedance tomography during maximum effort breathing and forced expiration maneuvers.

Ngo C, Leonhardt S, Zhang T, Lüken M, Misgeld B, Vollmer T, Tenbrock K, Lehmann S.

Physiol Meas. 2017 Jan;38(1):77-86. doi: 10.1088/1361-6579/38/1/77. Epub 2016 Dec 22.

PMID:
28004642
31.

Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening.

Vollmer T, Knabbe C, Dreier J.

Transfus Med Hemother. 2016 Nov;43(6):425-427. Epub 2016 Nov 2. No abstract available.

32.

Comparison of arousal and preference assessment outcomes for sex offenders with intellectual disabilities.

Reyes JR, Vollmer TR, Hall A.

J Appl Behav Anal. 2017 Jan;50(1):27-37. doi: 10.1002/jaba.364. Epub 2016 Oct 20.

PMID:
27766656
33.

Brain health: time matters in multiple sclerosis.

Giovannoni G, Butzkueven H, Dhib-Jalbut S, Hobart J, Kobelt G, Pepper G, Sormani MP, Thalheim C, Traboulsee A, Vollmer T.

Mult Scler Relat Disord. 2016 Sep;9 Suppl 1:S5-S48. doi: 10.1016/j.msard.2016.07.003. Epub 2016 Jul 7. Review.

34.

Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011.

Vollmer T, Diekmann J, Eberhardt M, Knabbe C, Dreier J.

Euro Surveill. 2016 Sep 1;21(35). doi: 10.2807/1560-7917.ES.2016.21.35.30332.

35.
36.

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis.

Calkwood J, Vollmer T, Fox RJ, Zhang R, Novas M, Sheikh SI, Viglietta V.

Int J MS Care. 2016 May-Jun;18(3):138-46. doi: 10.7224/1537-2073.2015-020.

37.

Determinants of high cost in multiple sclerosis patients: a claims and chart review study.

Ke X, Navaratnam P, Sasane R, Eisenberg Lawrence DF, Friedman HS, Tulsi BB, Vollmer T.

Curr Med Res Opin. 2016 Sep;32(9):1589-97. doi: 10.1080/03007995.2016.1192529. Epub 2016 Jun 25.

PMID:
27207562
38.

Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.

Phillips G, Guo S, Bender R, Havrdová E, Proskorovsky I, Vollmer T.

Mult Scler Relat Disord. 2016 Mar;6:66-72. doi: 10.1016/j.msard.2016.02.001. Epub 2016 Feb 1.

PMID:
27063626
39.

Autoimmune encephalitis: A more treatable tragedy if diagnosed early.

Vollmer TL, McCarthy M.

Neurology. 2016 May 3;86(18):1655-6. doi: 10.1212/WNL.0000000000002641. Epub 2016 Apr 1. No abstract available.

PMID:
27037233
40.

Implementation of NAT Screening for West Nile Virus and Experience with Seasonal Testing in Germany.

Dreier J, Vollmer T, Hinse D, Heuser EJ, Pisani G, Knabbe C.

Transfus Med Hemother. 2016 Jan;43(1):28-36. doi: 10.1159/000440833. Epub 2015 Sep 28.

41.

Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD.

Yan Y, Li Y, Fu Y, Yang L, Su L, Shi K, Li M, Liu Q, Borazanci A, Liu Y, He Y, Bennett JL, Vollmer TL, Shi FD.

Sci China Life Sci. 2016 Dec;59(12):1270-1281. Epub 2016 Feb 26.

42.

Establishment of a proficiency panel for an external quality assessment programme for the detection of bacterial contamination in platelet concentrates using rapid and cultural detection methods.

Vollmer T, Schmidt M, Hourfar K, Schottstedt V, Pichl L, Gubbe K, Knabbe C, Dreier J.

Vox Sang. 2016 May;110(4):336-43. doi: 10.1111/vox.12384. Epub 2016 Feb 5.

PMID:
26848941
43.

Daclizumab high-yield process reduced the evolution of new gadolinium-enhancing lesions to T1 black holes in patients with relapsing-remitting multiple sclerosis.

Radue EW, Sprenger T, Vollmer T, Giovannoni G, Gold R, Havrdova E, Selmaj K, Stefoski D, You X, Elkins J.

Eur J Neurol. 2016 Feb;23(2):412-5. doi: 10.1111/ene.12922.

PMID:
26806217
44.

Optimizing treatment success in multiple sclerosis.

Ziemssen T, Derfuss T, de Stefano N, Giovannoni G, Palavra F, Tomic D, Vollmer T, Schippling S.

J Neurol. 2016 Jun;263(6):1053-65. doi: 10.1007/s00415-015-7986-y. Epub 2015 Dec 24. Review.

45.

Bench Test for the Detection of Bacterial Contamination in Platelet Concentrates Using Rapid and Cultural Detection Methods with a Standardized Proficiency Panel.

Vollmer T, Knabbe C, Geilenkeuser WJ, Schmidt M, Dreier J.

Transfus Med Hemother. 2015 Jul;42(4):220-5. doi: 10.1159/000437396. Epub 2015 Jul 16.

46.

Relationship between brain volume loss and cognitive outcomes among patients with multiple sclerosis: a systematic literature review.

Vollmer T, Huynh L, Kelley C, Galebach P, Signorovitch J, DiBernardo A, Sasane R.

Neurol Sci. 2016 Feb;37(2):165-79. doi: 10.1007/s10072-015-2400-1. Epub 2015 Nov 4. Review.

PMID:
26537494
47.

Monitoring of in-hospital cardiac arrest events with the focus on Automated External Defibrillators--a retrospective observational study.

Wurmb T, Vollmer T, Sefrin P, Kraus M, Happel O, Wunder C, Steinisch A, Roewer N, Maier S.

Scand J Trauma Resusc Emerg Med. 2015 Oct 31;23:87. doi: 10.1186/s13049-015-0170-7.

48.

Incorporating real-world clinical practice in multiple sclerosis economic evaluations.

McQueen RB, Nair KV, Vollmer TL, Campbell JD.

Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):869-72. doi: 10.1586/14737167.2015.1081060. Epub 2015 Aug 20.

PMID:
26295727
49.

The natural history of brain volume loss among patients with multiple sclerosis: a systematic literature review and meta-analysis.

Vollmer T, Signorovitch J, Huynh L, Galebach P, Kelley C, DiBernardo A, Sasane R.

J Neurol Sci. 2015 Oct 15;357(1-2):8-18. doi: 10.1016/j.jns.2015.07.014. Epub 2015 Jul 13. Review.

PMID:
26238166
50.

Systematic Evaluation of Different Nucleic Acid Amplification Assays for Cytomegalovirus Detection: Feasibility of Blood Donor Screening.

Vollmer T, Knabbe C, Dreier J.

J Clin Microbiol. 2015 Oct;53(10):3219-25. doi: 10.1128/JCM.01091-15. Epub 2015 Jul 22.

Supplemental Content

Loading ...
Support Center